Jefferies Sticks to Their Buy Rating for NewAmsterdam Pharma …

Nov 19, 2024 · NewAmsterdam Pharma Company has an analyst consensus of Strong Buy, with a price target consensus of $37.67. See the top stocks recommended by analysts >> The …

CouponFollow Extension

$37.67
OFF

Jefferies Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

Nov 19, 2024 · NewAmsterdam Pharma Company has an analyst consensus of Strong Buy, with a price target consensus of $37.67. See the top stocks recommended by analysts >> The …

businessinsider.com

$35.00
OFF

Analysts Set NewAmsterdam Pharma (NASDAQ:NAMS) Price

3 weeks from now

Dec 26, 2024 · Scotiabank increased their price objective on shares of NewAmsterdam Pharma from $35.00 to $47.00 and gave the company a "sector outperform" rating in a research report …

marketbeat.com

$39.80
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Receives $39.80

3 weeks from now

Jan 20, 2025 · Scotiabank boosted their price objective on NewAmsterdam Pharma from $35.00 to $47.00 and gave the stock a "sector outperform" rating in a research note on Wednesday, …

marketbeat.com

$24
OFF

Jefferies Initiates Coverage On NewAmsterdam Pharma With Buy …

3 weeks from now

Jefferies analyst Dennis Ding initiates coverage on NewAmsterdam Pharma (NASDAQ:NAMS) with a Buy rating and announces Price Target of $24.

sparknewswire.com

$45.00
OFF

Strong Buy Rating For NewAmsterdam Pharma Backed By …

3 weeks from now

Aug 7, 2024 · In another report released on July 30, Jefferies also maintained a Buy rating on the stock with a $45.00 price target. See the top stocks recommended by analysts >>

businessinsider.com

$35
OFF

What 4 Analyst Ratings Have To Say About NewAmsterdam Pharma

3 weeks from now

Nov 7, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $35.0, a high estimate of $37.00, and a low estimate of …

nasdaq.com

$39.83
OFF

Where NewAmsterdam Pharma Stands With Analysts - Nasdaq

3 weeks from now

Dec 30, 2024 · In the assessment of 12-month price targets, analysts unveil insights for NewAmsterdam Pharma, presenting an average target of $39.83, a high estimate of $48.00, …

nasdaq.com

$32.67
OFF

NewAmsterdam Pharma (NASDAQ:NAMS) Stock, Analyst Ratings …

3 weeks from now

NewAmsterdam Pharma Co NV has a consensus price target of $32.67 based on the ratings of 11 analysts. The high is $48 issued by HC Wainwright & Co. on January 14, 2025.The low is …

benzinga.com

$43.83
OFF

RBC Capital Sticks To Their Buy Rating For NewAmsterdam Pharma …

3 weeks from now

5 days ago · NewAmsterdam Pharma Company has an analyst consensus of Strong Buy, with a price target consensus of $43.83. See the top stocks recommended by analysts >> The …

businessinsider.com

$479
OFF

NewAmsterdam Pharma Announces Closing Of Upsized $479.0 …

3 weeks from now

NAARDEN, The Netherlands and MIAMI, Dec. 13, 2024 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS; “NewAmsterdam” or the “Company”), a late-stage, …

newamsterdampharma.com